US Stock MarketDetailed Quotes

HRTX Heron Therapeutics

Watchlist
  • 3.220
  • +0.220+7.33%
Close May 16 16:00 ET
  • 3.240
  • +0.020+0.61%
Post 17:14 ET
485.10MMarket Cap-5854P/E (TTM)

Heron Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
61.78%-9.52M
59.98%-58.79M
106.54%2.46M
75.24%-9.18M
4.26%-27.17M
43.33%-24.9M
27.76%-146.91M
17.07%-37.53M
30.28%-37.07M
54.96%-28.37M
Net income from continuing operations
90.36%-3.16M
39.26%-110.56M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
17.52%-182.02M
63.64%-19.87M
20.04%-41.91M
7.63%-56.36M
Operating gains losses
----
-86.49%10K
---13K
--0
----
----
-91.00%74K
--0
---22K
--0
Depreciation and amortization
-4.04%689K
0.35%2.9M
-9.61%715K
2.97%727K
10.13%739K
-0.42%718K
-4.37%2.89M
-0.38%791K
-6.37%706K
-8.58%671K
Other non cash items
174.51%140K
67.82%339K
226.00%163K
40.38%73K
4.00%52K
2.00%51K
-77.65%202K
0.00%50K
-24.64%52K
-82.33%50K
Change In working capital
-1,811.36%-10.09M
259.81%16.79M
129.45%8.4M
224.00%8.53M
-97.71%386K
-106.59%-528K
70.05%-10.51M
-428.34%-28.53M
47.19%-6.88M
216.63%16.88M
-Change in receivables
-962.73%-5.19M
51.13%-8.09M
137.10%3.66M
784.24%12.9M
-3,255.63%-25.25M
110.72%601K
-360.59%-16.55M
-229.97%-9.86M
-300.21%-1.89M
119.56%800K
-Change in inventory
-114.44%-363K
301.31%12.46M
95.59%-103K
-71.19%2.62M
253.38%7.44M
131.08%2.51M
4.42%-6.19M
66.08%-2.33M
599.46%9.08M
-2,735.09%-4.85M
-Change in prepaid assets
-124.50%-222K
1,427.33%15.43M
203.58%4.89M
-89.43%172K
110.15%9.46M
323.70%906K
112.04%1.01M
-75.19%-4.72M
141.63%1.63M
381.60%4.5M
-Change in payables and accrued expense
4.99%-4.32M
-126.82%-3.01M
99.67%-38K
54.42%-7.16M
-46.84%8.73M
-120.57%-4.55M
142.25%11.23M
-240.19%-11.61M
-57.93%-15.7M
247.34%16.43M
Cash from discontinued investing activities
Operating cash flow
61.78%-9.52M
59.98%-58.79M
106.54%2.46M
75.24%-9.18M
4.26%-27.17M
43.33%-24.9M
27.76%-146.91M
17.07%-37.53M
30.28%-37.07M
54.96%-28.37M
Investing cash flow
Cash flow from continuing investing activities
-96.53%1.28M
641.37%18M
-537.21%-8.84M
35.58%-23.22M
-33.09%13.22M
236.51%36.83M
-110.16%-3.32M
108.33%2.02M
-266.62%-36.05M
-50.23%19.76M
Net PPE purchase and sale
--0
4.13%-1.53M
42.34%-237K
-744.72%-793K
13.66%-278K
77.33%-224K
46.56%-1.6M
-14.80%-411K
108.03%123K
-2.22%-322K
Net investment purchase and sale
-96.55%1.28M
1,231.34%19.53M
-453.58%-8.6M
37.99%-22.43M
-32.78%13.5M
210.52%37.06M
-104.83%-1.73M
110.18%2.43M
-256.14%-36.17M
-49.82%20.08M
Cash from discontinued investing activities
Investing cash flow
-96.53%1.28M
641.37%18M
-537.21%-8.84M
35.58%-23.22M
-33.09%13.22M
236.51%36.83M
-110.16%-3.32M
108.33%2.02M
-266.62%-36.05M
-50.23%19.76M
Financing cash flow
Cash flow from continuing financing activities
105.29%11K
-27.91%54.11M
-54.67%199K
-28.22%53.8M
1.27%319K
67.35%-208K
-51.89%75.06M
-9.86%439K
105,652.11%74.94M
-99.80%315K
Net issuance payments of debt
----
--24.35M
--0
----
----
----
--0
--0
----
----
Net common stock issuance
----
-60.40%29.76M
--0
----
----
----
--75.15M
---18K
----
----
Proceeds from stock option exercised by employees
105.29%11K
102.33%2K
-56.46%199K
-39.37%-308K
1.27%319K
67.35%-208K
-101.22%-86K
-6.16%457K
-325.00%-221K
-94.52%315K
Cash from discontinued financing activities
Financing cash flow
105.29%11K
-27.91%54.11M
-54.67%199K
-28.22%53.8M
1.27%319K
67.35%-208K
-51.89%75.06M
-9.86%439K
105,652.11%74.94M
-99.80%315K
Net cash flow
Beginning cash position
86.65%28.68M
-83.03%15.36M
-30.89%34.86M
-72.31%13.46M
-52.40%27.09M
-83.03%15.36M
-13.88%90.54M
-68.39%50.44M
-74.57%48.61M
-4.73%56.91M
Current changes in cash
-170.16%-8.23M
117.71%13.31M
82.37%-6.18M
1,069.87%21.4M
-64.15%-13.63M
134.87%11.73M
-415.02%-75.18M
49.19%-35.07M
105.79%1.83M
-106.32%-8.3M
End cash Position
-24.51%20.45M
86.65%28.68M
86.65%28.68M
-30.89%34.86M
-72.31%13.46M
-52.40%27.09M
-83.03%15.36M
-83.03%15.36M
-68.39%50.44M
-74.57%48.61M
Free cash flow
62.12%-9.52M
59.44%-60.33M
105.81%2.21M
73.13%-9.97M
4.36%-27.44M
44.15%-25.12M
27.93%-148.74M
16.87%-37.95M
32.15%-37.11M
54.67%-28.7M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 61.78%-9.52M59.98%-58.79M106.54%2.46M75.24%-9.18M4.26%-27.17M43.33%-24.9M27.76%-146.91M17.07%-37.53M30.28%-37.07M54.96%-28.37M
Net income from continuing operations 90.36%-3.16M39.26%-110.56M46.03%-10.72M40.33%-25.01M25.37%-42.06M48.71%-32.77M17.52%-182.02M63.64%-19.87M20.04%-41.91M7.63%-56.36M
Operating gains losses -----86.49%10K---13K--0---------91.00%74K--0---22K--0
Depreciation and amortization -4.04%689K0.35%2.9M-9.61%715K2.97%727K10.13%739K-0.42%718K-4.37%2.89M-0.38%791K-6.37%706K-8.58%671K
Other non cash items 174.51%140K67.82%339K226.00%163K40.38%73K4.00%52K2.00%51K-77.65%202K0.00%50K-24.64%52K-82.33%50K
Change In working capital -1,811.36%-10.09M259.81%16.79M129.45%8.4M224.00%8.53M-97.71%386K-106.59%-528K70.05%-10.51M-428.34%-28.53M47.19%-6.88M216.63%16.88M
-Change in receivables -962.73%-5.19M51.13%-8.09M137.10%3.66M784.24%12.9M-3,255.63%-25.25M110.72%601K-360.59%-16.55M-229.97%-9.86M-300.21%-1.89M119.56%800K
-Change in inventory -114.44%-363K301.31%12.46M95.59%-103K-71.19%2.62M253.38%7.44M131.08%2.51M4.42%-6.19M66.08%-2.33M599.46%9.08M-2,735.09%-4.85M
-Change in prepaid assets -124.50%-222K1,427.33%15.43M203.58%4.89M-89.43%172K110.15%9.46M323.70%906K112.04%1.01M-75.19%-4.72M141.63%1.63M381.60%4.5M
-Change in payables and accrued expense 4.99%-4.32M-126.82%-3.01M99.67%-38K54.42%-7.16M-46.84%8.73M-120.57%-4.55M142.25%11.23M-240.19%-11.61M-57.93%-15.7M247.34%16.43M
Cash from discontinued investing activities
Operating cash flow 61.78%-9.52M59.98%-58.79M106.54%2.46M75.24%-9.18M4.26%-27.17M43.33%-24.9M27.76%-146.91M17.07%-37.53M30.28%-37.07M54.96%-28.37M
Investing cash flow
Cash flow from continuing investing activities -96.53%1.28M641.37%18M-537.21%-8.84M35.58%-23.22M-33.09%13.22M236.51%36.83M-110.16%-3.32M108.33%2.02M-266.62%-36.05M-50.23%19.76M
Net PPE purchase and sale --04.13%-1.53M42.34%-237K-744.72%-793K13.66%-278K77.33%-224K46.56%-1.6M-14.80%-411K108.03%123K-2.22%-322K
Net investment purchase and sale -96.55%1.28M1,231.34%19.53M-453.58%-8.6M37.99%-22.43M-32.78%13.5M210.52%37.06M-104.83%-1.73M110.18%2.43M-256.14%-36.17M-49.82%20.08M
Cash from discontinued investing activities
Investing cash flow -96.53%1.28M641.37%18M-537.21%-8.84M35.58%-23.22M-33.09%13.22M236.51%36.83M-110.16%-3.32M108.33%2.02M-266.62%-36.05M-50.23%19.76M
Financing cash flow
Cash flow from continuing financing activities 105.29%11K-27.91%54.11M-54.67%199K-28.22%53.8M1.27%319K67.35%-208K-51.89%75.06M-9.86%439K105,652.11%74.94M-99.80%315K
Net issuance payments of debt ------24.35M--0--------------0--0--------
Net common stock issuance -----60.40%29.76M--0--------------75.15M---18K--------
Proceeds from stock option exercised by employees 105.29%11K102.33%2K-56.46%199K-39.37%-308K1.27%319K67.35%-208K-101.22%-86K-6.16%457K-325.00%-221K-94.52%315K
Cash from discontinued financing activities
Financing cash flow 105.29%11K-27.91%54.11M-54.67%199K-28.22%53.8M1.27%319K67.35%-208K-51.89%75.06M-9.86%439K105,652.11%74.94M-99.80%315K
Net cash flow
Beginning cash position 86.65%28.68M-83.03%15.36M-30.89%34.86M-72.31%13.46M-52.40%27.09M-83.03%15.36M-13.88%90.54M-68.39%50.44M-74.57%48.61M-4.73%56.91M
Current changes in cash -170.16%-8.23M117.71%13.31M82.37%-6.18M1,069.87%21.4M-64.15%-13.63M134.87%11.73M-415.02%-75.18M49.19%-35.07M105.79%1.83M-106.32%-8.3M
End cash Position -24.51%20.45M86.65%28.68M86.65%28.68M-30.89%34.86M-72.31%13.46M-52.40%27.09M-83.03%15.36M-83.03%15.36M-68.39%50.44M-74.57%48.61M
Free cash flow 62.12%-9.52M59.44%-60.33M105.81%2.21M73.13%-9.97M4.36%-27.44M44.15%-25.12M27.93%-148.74M16.87%-37.95M32.15%-37.11M54.67%-28.7M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg